Nationwide Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-41,085
| Closed | -$735K | – | 2041 |
|
|
2017
Q3 | $735K | Sell |
41,085
-600
| -1% | -$10.7K | ﹤0.01% | 1974 |
|
|
2017
Q2 | $679K | Buy |
41,685
+6,238
| +18% | +$102K | ﹤0.01% | 2011 |
|
|
2017
Q1 | $496K | Sell |
35,447
-4,190
| -11% | -$58.6K | ﹤0.01% | 2159 |
|
|
2016
Q4 | $632K | Sell |
39,637
-1,543
| -4% | -$24.6K | ﹤0.01% | 2038 |
|
|
2016
Q3 | $685K | Sell |
41,180
-2,513
| -6% | -$41.8K | ﹤0.01% | 2003 |
|
|
2016
Q2 | $489K | Buy |
43,693
+17,523
| +67% | +$196K | ﹤0.01% | 2159 |
|
|
2016
Q1 | $219K | Sell |
26,170
-1,304
| -5% | -$10.9K | ﹤0.01% | 2496 |
|
|
2015
Q4 | $256K | Buy |
27,474
+456
| +2% | +$4.25K | ﹤0.01% | 2427 |
|
|
2015
Q3 | $305K | Hold |
27,018
| – | – | ﹤0.01% | 2364 |
|
|
2015
Q2 | $343K | Buy |
27,018
+226
| +0.8% | +$2.87K | ﹤0.01% | 2446 |
|
|
2015
Q1 | $249K | Sell |
26,792
-3,249
| -11% | -$30.2K | ﹤0.01% | 2584 |
|
|
2014
Q4 | $430K | Buy |
30,041
+3,643
| +14% | +$52.1K | ﹤0.01% | 2271 |
|
|
2014
Q3 | $274K | Buy |
26,398
+154
| +0.6% | +$1.6K | ﹤0.01% | 2539 |
|
|
2014
Q2 | $425K | Buy |
26,244
+619
| +2% | +$10K | ﹤0.01% | 2351 |
|
|
2014
Q1 | $416K | Sell |
25,625
-60,226
| -70% | -$978K | ﹤0.01% | 2139 |
|
|
2013
Q4 | $1.07M | Sell |
85,851
-66,811
| -44% | -$829K | ﹤0.01% | 1830 |
|
|
2013
Q3 | $1.68M | Buy |
152,662
+131,446
| +620% | +$1.44M | 0.01% | 1542 |
|
|
2013
Q2 | $171K | Buy |
+21,216
| New | +$171K | ﹤0.01% | 2557 |
|